Stock listing
A2QAR3 Stock Price, News, Filings & Events — Achieve Life Sciences, Inc.
Selected listing: A2QAR3 · LS · EUR · DE
This page tracks Achieve Life Sciences, Inc.'s A2QAR3:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2QAR3:LS. A2QAR3:LS is the stock-level entry point for investors researching Achieve Life Sciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2QAR3:LS
- Asset type
- Stock
- Market cap
- $833.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Achieve Life Sciences, Inc. A2QAR3:LS stock context
This page tracks Achieve Life Sciences, Inc.'s A2QAR3:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2QAR3:LS. A2QAR3:LS is the stock-level entry point for investors researching Achieve Life Sciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Achieve Life Sciences, Inc.
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 11, 2026
Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality
August 3, 2026
Achieve Life Sciences Joins Russell 2000® Index
June 29, 2026
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
June 22, 2026
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
June 2, 2026
Achieve Life Sciences, Inc. earnings calls
Achieve Life Sciences, Inc. (ACHV) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call
March 24, 2026 · Replay with transcript and chapters
Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call
March 11, 2025 · Replay with transcript and chapters
Research Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. investor report
Review AI stock analysis and investor report context for A2QAR3:LS.
Achieve Life Sciences, Inc. company profile
View the public company page for Achieve Life Sciences, Inc. on 6ix.
Achieve Life Sciences, Inc. news
Read company news and market updates connected to Achieve Life Sciences, Inc..
Achieve Life Sciences, Inc. investor events
Find investor webinars, events, and replay context for Achieve Life Sciences, Inc..
Alternate listings
ACHV:NASDAQ
US · USD
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
SP4P:GETTEX
DE · EUR
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
SP4P:MUN
DE · EUR
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
ACHV:BOATS
US · USD
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
A2QAR3:LSX
DE · EUR
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
SP4P:TRADEGATE
DE · EUR
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
SP4P:FWB
DE · EUR
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
SP4P:SWB
DE · EUR
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
SP4P:DUS
DE · EUR
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.
SP4P:HAM
DE · EUR
Alternate listing for Achieve Life Sciences, Inc.; the primary context on this page is A2QAR3:LS.